Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)

So far, Altmetric has seen 9 X posts from 5 X users, with an upper bound of 20,772 followers.

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. https://t.co/OzlgIDN7I4

RT @sitcancer: #JITC Research: Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients h…

RT @sitcancer: #JITC Research: Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients h…

#JITC Research: Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients https://t.co/IamQjOy22Z https://t.co/jyAkgD9boY

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.